Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome 2024-04-26 23:46
Antengene Announces One Oral and Three Poster Presentations at ASCO 2024 2024-04-25 20:00
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease (GERD) 2024-04-25 19:57
Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine 2024-04-25 16:07
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting 2024-04-25 10:02
CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy 2024-04-24 15:00
RELIFE BY A. MENARINI CHAMPIONS PERSONAL CHOICE IN AESTHETIC TREATMENTS, ENCOURAGING SELF-CARE AND SELF-LOVE 2024-04-24 10:00
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay 2024-04-22 08:27
CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US 2024-04-20 01:11
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success 2024-04-19 21:00
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 2024-04-19 19:00
Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions 2024-04-18 21:00
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine 2024-04-18 20:00
Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement 2024-04-18 15:01
Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL" 2024-04-18 11:00
Q1 2024 Revenue and Business Update 2024-04-17 15:05
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA 2024-04-17 11:22
CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution 2024-04-16 20:47
YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 2024-04-16 20:00
1 2 3 4 5 228